Jinsoo Chung

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 262 citations · Full text

Lymphovascular Invasion in Transurethral Resection Specimens as Predictor of Progression and Metastasis in Patients With Newly Diagnosed T1 Bladder Urothelial Cancer

Kang Su Cho, Ho Kyung Seo, Jae Young Joung et al. · The Journal of Urology · 2009 · 106 citations

Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma

Tobias Klatte, Jinsoo Chung, John T. Leppert et al. · British Journal of Urology · 2007 · 72 citations

Efficacy and oncologic safety of nerve-sparing radical hysterectomy for cervical cancer: a randomized controlled trial

Ju‐Won Roh, Dong Ock Lee, Dong Hoon Suh et al. · Journal of Gynecologic Oncology · 2015 · 68 citations · Full text

Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma

Sung Han Kim, Boram Park, Eu Chang Hwang et al. · Frontiers in Oncology · 2019 · 63 citations · Full text